Methods for treatment of insulin-like growth factor-1 (IGF-1) deficiency

Details for Australian Patent Application No. 2004291833 (hide)

Owner Tercica, Inc.

Inventors Clark, Ross G.

Agent FB Rice

Pub. Number AU-B-2004291833

PCT Pub. Number WO2005/049792

Priority 60/502,579 12.09.03 US

Filing date 9 September 2004

Wipo publication date 2 June 2005

Acceptance publication date 26 August 2010

International Classifications

A01N 37/18 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids - containing the group CON, e.g. carboxylic acid amides or imides

Event Publications

6 April 2006 PCT application entered the National Phase

  PCT publication WO2005/049792 Priority application(s): WO2005/049792

26 August 2010 Application Accepted

  Published as AU-B-2004291833

23 December 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004291837-Detection of a concealed object

2004291828-Synthetic mammalian retrotransposon gene